Collateral Sensitivity to β-Lactam Antibiotics in Evolved Apramycin-Resistant MRSA
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212292 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jingjing Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, South China Agricultural University, Guangzhou 510642, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, beta-Lactams, Nebramycin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Foundation for Innovative Research Groups of the National Natural Science Foundation of China, Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program, National key research and development program of China.
Abstract (Originalsprache)
Collateral sensitivity is an evolutionary trade-off for bacteria where acquiring resistance to one antibiotic results in an increased sensitivity to another antibiotic. This study was designed to evaluate the collateral sensitivity of methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics induced by the evolution of resistance to apramycin. Collateral sensitivity to ampicillin, cephazolin, ceftriaxone, cefotaxime, cefepime and cefquinome occurred after MRSA were exposed to apramycin and induced to acquire resistance. This sensitivity was associated with reduced β-lactamase activity and decreased expression of the mecA gene. We also found a decrease in the proton motive force and decreased efflux activity. These results provide new insights into collateral sensitivity-based strategies for the treatment of MRSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Animal Disease Control and Prevention, South China Agricultural University, Guangzhou 510642, China.
- National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou 510642, China.
- Guangdong Wenshi Dahuanong Biotechnology Co., Ltd., Yunfu 527400, China.
- Animal Laboratory Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Förderung
- the Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program
- National key research and development program of China
- Laboratory of Lingnan Modern Agriculture Project
- National Key Research & Development Program of China
- Double first-class discipline promotion project
- the 111 Center
- the National Natural Science Foundation of China
Zitieren
APA
Wu, J., Wu, S., Liu, J., Li, C., Zheng, M., Li, F., Zhang, Y., Wu, Y., & Yu, Y. (2024). Collateral Sensitivity to β-Lactam Antibiotics in Evolved Apramycin-Resistant MRSA. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212292
Vancouver
Wu J, Wu S, Liu J, Li C, Zheng M, Li F, et al. Collateral Sensitivity to β-Lactam Antibiotics in Evolved Apramycin-Resistant MRSA. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212292
BibTeX
@article{Wu2024,
author = {Wu, Jingjing and Wu, Shiqian and Liu, Juan and Li, Changmin and Zheng, Mei and Li, Fuhao and Zhang, Yan and Wu, Yashuang and Yu, Yang},
title = {Collateral Sensitivity to β-Lactam Antibiotics in Evolved Apramycin-Resistant MRSA},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212292}
}
EUVIMED